FDA Inspection 869792 — Stryker Corporation

Stryker Corporation — FEI 3009390713

The FDA completed an inspection of Stryker Corporation on Mar 12, 2014 in Minnetonka, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 12, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Minnetonka, MN (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.